Comparison of Brain Natriuretic Peptide Plasma Levels Versus Logistic EuroSCORE in Predicting In-Hospital and Late Postoperative Mortality in Patients Undergoing Aortic Valve Replacement for Symptomatic Aortic Stenosis

American Journal of Cardiology

Volumn 102, Issue 6, 2008, Pages 749-754

  Pedrazzini, Giovanni Battista ^a   Masson, Serge ^b   Latini, Roberto ^b   Klersy, Catherine ^c   Rossi, Maria Grazia ^a   Pasotti, Elena ^a   Faletra, Francesco Fulvio ^a   Siclari, Francesco ^d   Minervini, Fabrizio ^d   Moccetti, Tiziano ^a   Auricchio, Angelo ^a  

^a Division of Cardiology   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d Division of Cardiac Surgery   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACCURACY; ADULT; AGED; AKAIKE METHOD; ALGORITHM; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BYPASS SURGERY; COMPARATIVE STUDY; CORRELATION ANALYSIS; EUROPEAN SYSTEM FOR CARDIAC OPERATIVE RISK EVALUATION; FEMALE; HAZARD RATIO; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL MORTALITY; TECHNIQUE;

AGE FACTORS; AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HOSPITAL MORTALITY; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; OUTCOME ASSESSMENT (HEALTH CARE); PREOPERATIVE CARE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 50949122702     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.04.055     Document Type: Article

References (26)

1. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., and Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16 (1999) 9-13
2. Nashef S.A., Roques F., Hammill B.G., Peterson E.D., Michel P., Grover F.L., Wyse R.K., Ferguson T.B., and EuroSCORE Project Group. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 22 (2002) 101-105
3. Roques F., Nashef S.A., Michel P., Gauducheau E., de Vincentiis C., Baudet E., Cortina J., David M., Faichney A., Gabrielle F., et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg 15 (1999) 816-822
4. Roques F., Michel P., Goldstone A.R., and Nashef S.A.M. The logistic EuroSCORE [Letter to Editor]. European Heart J 24 (2003) 1-2
5. Bhatti F., Grayson A.D., Grotte G., Fabri B.M., Au J., Jones M., Bridgewater B., and North West Quality Improvement Programme in Cardiac Interventions. The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk?. Heart 92 (2006) 1817-1820
6. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., Omland T., Storrow A.B., Abraham W.T., Wu A.H., et al., Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
7. Weber M., Dill T., Arnold R., Rau M., Ekinci O., Muller K.D., Berkovitsch A., Mitrovic V., and Hamm C. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
8. De Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
9. Berger R., Huelsman M., Strecker K., Bojic A., Moser P., Stanek B., and Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105 (2002) 2392-2397
10. Suzuki S., Yoshimura M., Nakayama M., Mizuno Y., Harada E., Ito T., Nakamura S., Abe K., Yamamuro M., Sakamoto T., et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 110 (2004) 1387-1391
11. Patel D.N., and Bailey S.R. Role of BNP in patients with severe asymptomatic aortic stenosis. Eur Heart J 25 (2004) 1972-1973
12. Weber M., Arnold R., Rau M., Brandt R., Berkovitsch A., Mitrovic V., and Hamm C. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 94 (2004) 740-745
13. Gerber I.L., Stewart R.A., Legget M.E., West T.M., French R.L., Sutton T.M., Yandle T.G., French J.K., Richards A.M., and White H.D. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 107 (2003) 1884-1890
14. Gerber I.L., Legget M.E., West T.M., Richards A.M., and Stewart R.A. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol 95 (2005) 898-901
15. Kupari M., Turto H., Lommi J., Mäkiyärvi, and Parikka H. Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis. Eur J Heart Fail 7 (2005) 809-814
16. Neverdal N.O., Knudsen C.W., Husebye T., Vengen O.A., Pepper J., Lie M., and Tonnessen T. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis: one year follow-up. Eur J Heart Fail 8 (2006) 257-262
17. Qi W., Mathisen P., Kjesshus J., Simonsen S., Bjornerheim R., Endresen K., and Hall C. Natriuretic peptides in patients with aortic stenosis. Am Heart J 142 (2001) 725-732
18. Salehian O., and Chan K.L. Should brain natriuretic peptides be measured in patients with aortic valve disease?. Eur Heart J 26 (2005) 951-952
19. Weber M., Arnold R., Rau M., Elsaesser A., Brandt R., Mitrovic V., and Hamm C. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J (2005) 1023-1030
20. Elíasdóttir S.B., Klemenzson G., Torfason B., and Valsson F. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Acta Anaesthesiol Scand 52 (2008) 182-187
21. Bergler-Klein J., Klaar U., Heger M., Rosenhek R., Mundigler G., Gabriel H., Binder T., Pacher R., Maurer G., and Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 109 (2004) 2302-2308
22. Weber M., Hausen M., Arnold R., Nef H., Moellman H., Berkowitsch A., Elsaesser A., Brandt R., Mitrovic V., and Hamm C. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Heart 92 (2006) 1639-1644
23. Toumpoulis I.K., Anagnostopoulos C.E., Toumpoulis S.K., DeRose Jr. J.J., and Swistel D.G. EuroSCORE predicts long-term mortality after heart valve surgery. Ann Thorac Surg 79 (2005) 1902-1908
24. Giannakoulas G., Hatzitolios A., Karvounis H., Koliakos G., Charitandi A., Dimitroulas T., Savopoulos C., Tsirogianni E., and Louridas G. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology 56 (2005) 723-730
25. Iltumur K., Yavavli A., Apak I., Ariturk Z., and Toprak N. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J 151 (2006) 1115-1122
26. Heart Protection Study Collaborative Group, Emberson J.R., Ng L.L., Armitage J., Bowman L., Parish S., and Collins R. N-terminal pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol 49 (2007) 311-319